المؤلفون: Calais, J, Czernin, J, Eiber, M, Fendler, WP, Gartmann, J, Heaney, AP, Hendifar, AE, Pisegna, JR, Hecht, JR, Wolin, EM, Slavik, R, Gupta, P, Quon, A, Schiepers, C, Allen-Auerbach, MS, Herrmann, K

المصدر: Calais, J; Czernin, J; Eiber, M; Fendler, WP; Gartmann, J; Heaney, AP; et al.(2017). Most of the Intended Management Changes After Ga-68-DOTATATE PET/CT Are Implemented. JOURNAL OF NUCLEAR MEDICINE, 58(11), 1793-1796. doi: 10.2967/jnumed.117.192450. UCLA: Retrieved from: http://www.escholarship.org/uc/item/0xm8s30w

مصطلحات موضوعية: somatostatin receptor, DOTATATE, impact on implemented management, PET/CT, neuroendocrine tumors

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od_______325::5a852988acae2dadc15492d61f5e51fc
http://www.escholarship.org/uc/item/0xm8s30w

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Benz MR, Czernin J, Allen-Auerbach MS, Dry SM, Sutthiruangwong P, Spick C, Radu C, Weber WA, Tap WD, Eilber FC, Benz, Matthias R, Czernin, Johannes, Allen-Auerbach, Martin S, Dry, Sarah M, Sutthiruangwong, Piriya, Spick, Claudio, Radu, Caius, Weber, Wolfgang A, Tap, William D, Eilber, Fritz C

المصدر: Cancer (0008543X); Jun2012, Vol. 118 Issue 12, p3135-3144, 10p

المؤلفون: Labora A; Department of Surgery, University of California, Los Angeles, CA, USA. alabora@mednet.ucla.edu., Shimizu T; Department of Surgery, University of California, Los Angeles, CA, USA., Moore A; Department of Surgery, University of California, Los Angeles, CA, USA., Premji A; Department of Surgery, University of California, Los Angeles, CA, USA., Armstrong WR; David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Chen KY; David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Link J; Department of Surgery, University of California, Los Angeles, CA, USA., Chan CS; Department of Surgery, University of California, Los Angeles, CA, USA., Allen-Auerbach MS; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, USA., Donahue TR; Department of Surgery, University of California, Los Angeles, CA, USA.

المصدر: Annals of surgical oncology [Ann Surg Oncol] 2024 Jun 22. Date of Electronic Publication: 2024 Jun 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

المؤلفون: Unterrainer LM; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California.; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany., Ruchalski K; Department of Radiological Sciences, UCLA, Los Angeles, California; and., Allen-Auerbach MS; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California., Calais J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California., Benz MR; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California; mbenz@mednet.ucla.edu.; Department of Radiological Sciences, UCLA, Los Angeles, California; and.; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany.

المصدر: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 May 01; Vol. 65 (5), pp. 818-819. Date of Electronic Publication: 2024 May 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

مواضيع طبية MeSH: Positron Emission Tomography Computed Tomography*, Humans ; Glutamate Carboxypeptidase II/metabolism ; Antigens, Surface/metabolism ; Prostatic Neoplasms/diagnostic imaging ; Male

المؤلفون: Yu R; Division of Endocrinology, UCLA David Geffen School of Medicine, Los Angeles, California., Allen-Auerbach MS; Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, UCLA David Geffen School of Medicine, Los Angeles, California., Yeh MW; Section of Endocrine Surgery, UCLA David Geffen School of Medicine, Los Angeles, California.

المصدر: AACE clinical case reports [AACE Clin Case Rep] 2024 Feb 08; Vol. 10 (3), pp. 117-118. Date of Electronic Publication: 2024 Feb 08 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101670593 Publication Model: eCollection Cited Medium: Internet ISSN: 2376-0605 (Electronic) Linking ISSN: 23760605 NLM ISO Abbreviation: AACE Clin Case Rep Subsets: PubMed not MEDLINE

المؤلفون: Larson SM; Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, California.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California., Walthers CM; Department of Microbiology, Immunology and Molecular Genetics, UCLA, Los Angeles, California., Ji B; Department of Microbiology, Immunology and Molecular Genetics, UCLA, Los Angeles, California., Ghafouri SN; Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, California., Naparstek J; Parker Institute for Cancer Immunotherapy Center at UCLA, Los Angeles, California., Trent J; Parker Institute for Cancer Immunotherapy Center at UCLA, Los Angeles, California., Chen JM; Parker Institute for Cancer Immunotherapy Center at UCLA, Los Angeles, California., Roshandell M; Department of Microbiology, Immunology and Molecular Genetics, UCLA, Los Angeles, California., Harris C; Department of Microbiology, Immunology and Molecular Genetics, UCLA, Los Angeles, California., Khericha M; Department of Microbiology, Immunology and Molecular Genetics, UCLA, Los Angeles, California., Schweppe T; Department of Microbiology, Immunology and Molecular Genetics, UCLA, Los Angeles, California., Berent-Maoz B; Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, California.; Parker Institute for Cancer Immunotherapy Center at UCLA, Los Angeles, California., Gosliner SB; Department of Chemical and Biomolecular Engineering, UCLA, Los Angeles, California., Almaktari A; Department of Microbiology, Immunology and Molecular Genetics, UCLA, Los Angeles, California., Ceja MA; Department of Microbiology, Immunology and Molecular Genetics, UCLA, Los Angeles, California., Allen-Auerbach MS; Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, California., Said J; Department of Pathology and Laboratory Medicine, UCLA, Los Angeles, California., Nawaly K; Parker Institute for Cancer Immunotherapy Center at UCLA, Los Angeles, California., Mead M; Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, California., de Vos S; Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, California.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California., Young PA; Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, California., Oliai C; Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, California., Schiller GJ; Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, California.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California., Timmerman JM; Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, California.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California., Ribas A; Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, California.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California.; Parker Institute for Cancer Immunotherapy Center at UCLA, Los Angeles, California.; Department of Surgery, Division of Surgical Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California.; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California., Chen YY; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California.; Department of Microbiology, Immunology and Molecular Genetics, UCLA, Los Angeles, California.; Parker Institute for Cancer Immunotherapy Center at UCLA, Los Angeles, California.; Department of Chemical and Biomolecular Engineering, UCLA, Los Angeles, California.

المصدر: Cancer discovery [Cancer Discov] 2023 Mar 01; Vol. 13 (3), pp. 580-597.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, Chimeric Antigen*/genetics , Lymphoma, Non-Hodgkin*/therapy, Humans ; Cytokine Release Syndrome/etiology ; Cytokine Release Syndrome/therapy ; Memory T Cells ; Immunotherapy, Adoptive/adverse effects ; Antigens, CD19

المؤلفون: Sun N; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States; Key Laboratory for Nano-Bio Interface, Suzhou Institute of Nano-Tech and Nano-Bionics, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Suzhou, 215123, PR China., Yang Y; Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States; Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100730, PR China., Miao H; Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States; Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100730, PR China., Redublo P; Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States., Liu H; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States., Liu W; Department of Chemistry and Biochemistry, Department of Bioengineering, Department of Materials Science and Engineering, California NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA, 90095, United States., Huang YW; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States., Teng PC; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, United States., Zhang C; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States; Department of Pathology, Southern Medical University, Guangzhou, 510515, Guangdong Province, PR China., Zhang RY; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States., Smalley M; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States., Yang P; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States., Chou SJ; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States., Huai K; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States., Zhang Z; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States., Lee YT; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States., Wang JJ; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, United States., Wang J; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States., Liang IY; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States., Zhang TX; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States., Zhang D; Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States., Liang L; Department of Pathology, Southern Medical University, Guangzhou, 510515, Guangdong Province, PR China., Weiss PS; Department of Chemistry and Biochemistry, Department of Bioengineering, Department of Materials Science and Engineering, California NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA, 90095, United States., Posadas EM; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, United States., Donahue T; Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States., Hecht JR; Department of Medicine, Division of Hematology Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States., Allen-Auerbach MS; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States., Bergsland EK; Department of Clinical Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, 94158, United States., Hope TA; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, 94158, United States., Pei R; Key Laboratory for Nano-Bio Interface, Suzhou Institute of Nano-Tech and Nano-Bionics, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Suzhou, 215123, PR China. Electronic address: rjpei2011@sinano.ac.cn., Zhu Y; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States. Electronic address: yazhenzhu@mednet.ucla.edu., Tseng HR; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States. Electronic address: hrtseng@mednet.ucla.edu., Heaney AP; Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States. Electronic address: aheaney@mednet.ucla.edu.

المصدر: Biosensors & bioelectronics [Biosens Bioelectron] 2022 Mar 01; Vol. 199, pp. 113854. Date of Electronic Publication: 2021 Dec 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Advanced Technology Country of Publication: England NLM ID: 9001289 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4235 (Electronic) Linking ISSN: 09565663 NLM ISO Abbreviation: Biosens Bioelectron Subsets: MEDLINE

مواضيع طبية MeSH: Biosensing Techniques* , Neoplastic Cells, Circulating*/pathology , Neuroendocrine Tumors*, Biomarkers, Tumor ; Humans ; Neoplasm Metastasis

المؤلفون: Hotta M; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. MHotta@mednet.ucla.edu., Benz MR; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Allen-Auerbach MS; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Crompton JG; Division of Surgical Oncology, Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Roth MD; Department of Medicine, Division of Pulmonary & Critical Care, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Eilber FC; Division of Surgical Oncology, Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Calais J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

المصدر: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Feb; Vol. 49 (3), pp. 1088-1089. Date of Electronic Publication: 2021 Sep 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE

مواضيع طبية MeSH: Lipoma*/complications , Lipoma*/diagnostic imaging , Quinolines*, Gallium Radioisotopes ; Granuloma ; Humans ; Positron Emission Tomography Computed Tomography